Newron Pharmaceuticals SpA historical data
| Date | Open | High | Low | Close | Adj. close | Volume |
|---|---|---|---|---|---|---|
| 2023-03-15 | 6.080 | 6.420 | 5.480 | 5.500 | 5.500 | 199,780 |
| 2023-03-14 | 5.320 | 5.900 | 4.830 | 5.900 | 5.900 | 148,742 |
| 2023-03-13 | 5.920 | 5.940 | 5.300 | 5.360 | 5.360 | 112,512 |
| 2023-03-10 | 5.700 | 6.180 | 5.680 | 5.920 | 5.920 | 50,663 |
| 2023-03-09 | 5.960 | 6.200 | 5.620 | 6.040 | 6.040 | 73,687 |
| 2023-03-08 | 5.920 | 6.000 | 5.780 | 5.960 | 5.960 | 63,396 |
| 2023-03-07 | 5.840 | 6.220 | 5.740 | 6.020 | 6.020 | 97,935 |
| 2023-03-06 | 5.980 | 6.380 | 5.800 | 6.220 | 6.220 | 304,736 |
| 2023-03-03 | 5.500 | 5.960 | 5.400 | 5.920 | 5.920 | 148,883 |
| 2023-03-02 | 6.020 | 6.180 | 4.900 | 5.400 | 5.400 | 534,870 |
| 2023-03-01 | 6.500 | 6.600 | 5.840 | 6.040 | 6.040 | 160,431 |
| 2023-02-28 | 6.740 | 6.740 | 6.300 | 6.500 | 6.500 | 63,146 |
| 2023-02-27 | 6.260 | 7.480 | 6.200 | 6.680 | 6.680 | 291,262 |
| 2023-02-24 | 7.080 | 7.360 | 6.200 | 6.380 | 6.380 | 347,909 |
| 2023-02-23 | 6.000 | 6.900 | 5.720 | 6.860 | 6.860 | 313,465 |
| 2023-02-22 | 6.480 | 6.480 | 5.520 | 5.900 | 5.900 | 516,063 |
| 2023-02-21 | 8.520 | 9.180 | 5.820 | 6.840 | 6.840 | 1,493,471 |
| 2023-02-20 | 6.320 | 8.180 | 6.320 | 8.000 | 8.000 | 855,023 |
| 2023-02-17 | 5.100 | 6.080 | 5.100 | 6.040 | 6.040 | 697,747 |
| 2023-02-16 | 4.810 | 5.140 | 4.800 | 5.060 | 5.060 | 455,657 |
| 2023-02-15 | 4.540 | 4.540 | 4.190 | 4.260 | 4.260 | 47,137 |
| 2023-02-14 | 4.680 | 4.680 | 4.380 | 4.530 | 4.530 | 38,559 |
| 2023-02-13 | 4.330 | 4.700 | 4.260 | 4.380 | 4.380 | 115,485 |
| 2023-02-10 | 4.580 | 4.640 | 4.010 | 4.330 | 4.330 | 259,095 |
| 2023-02-09 | 4.200 | 5.000 | 4.200 | 4.740 | 4.740 | 569,211 |
| 2023-02-08 | 3.570 | 4.220 | 3.570 | 4.150 | 4.150 | 441,368 |
| 2023-02-07 | 3.470 | 3.600 | 3.400 | 3.540 | 3.540 | 149,510 |
| 2023-02-06 | 3.170 | 3.520 | 3.110 | 3.500 | 3.500 | 337,535 |
| 2023-02-03 | 3.010 | 3.170 | 3.000 | 3.170 | 3.170 | 86,462 |
| 2023-02-02 | 3.150 | 3.170 | 3.050 | 3.130 | 3.130 | 40,933 |
| 2023-02-01 | 3.160 | 3.170 | 3.060 | 3.120 | 3.120 | 29,913 |
| 2023-01-31 | 3.170 | 3.170 | 3.060 | 3.090 | 3.090 | 27,403 |
| 2023-01-30 | 3.110 | 3.170 | 3.050 | 3.170 | 3.170 | 29,998 |
| 2023-01-27 | 3.000 | 3.120 | 2.950 | 3.120 | 3.120 | 66,694 |
| 2023-01-26 | 3.060 | 3.120 | 2.930 | 3.100 | 3.100 | 100,365 |
| 2023-01-25 | 2.940 | 3.240 | 2.930 | 3.120 | 3.120 | 385,653 |
| 2023-01-24 | 2.630 | 2.970 | 2.600 | 2.970 | 2.970 | 252,525 |
| 2023-01-23 | 2.550 | 2.630 | 2.430 | 2.620 | 2.620 | 59,562 |
| 2023-01-20 | 2.540 | 2.540 | 2.400 | 2.520 | 2.520 | 55,704 |
| 2023-01-19 | 2.300 | 2.550 | 2.300 | 2.540 | 2.540 | 35,753 |
| 2023-01-18 | 2.280 | 2.360 | 2.250 | 2.350 | 2.350 | 26,122 |
| 2023-01-17 | 2.420 | 2.430 | 2.270 | 2.370 | 2.370 | 26,953 |
| 2023-01-16 | 2.500 | 2.500 | 2.320 | 2.430 | 2.430 | 40,513 |
| 2023-01-13 | 2.430 | 2.500 | 2.200 | 2.500 | 2.500 | 95,315 |
| 2023-01-12 | 2.550 | 2.650 | 2.300 | 2.400 | 2.400 | 126,944 |
| 2023-01-11 | 2.740 | 2.790 | 2.540 | 2.640 | 2.640 | 95,490 |
| 2023-01-10 | 2.860 | 2.910 | 2.700 | 2.840 | 2.840 | 70,962 |
| 2023-01-09 | 2.750 | 2.970 | 2.750 | 2.940 | 2.940 | 142,899 |
| 2023-01-06 | 3.250 | 3.270 | 2.580 | 2.730 | 2.730 | 367,158 |
| 2023-01-05 | 2.500 | 3.300 | 2.500 | 3.250 | 3.250 | 921,714 |
| 2023-01-04 | 1.895 | 2.300 | 1.890 | 2.270 | 2.270 | 309,400 |
| 2023-01-03 | 1.860 | 1.995 | 1.750 | 1.805 | 1.805 | 257,589 |
| 2022-12-30 | 1.500 | 1.550 | 1.450 | 1.550 | 1.550 | 9,085 |
| 2022-12-29 | 1.440 | 1.495 | 1.425 | 1.495 | 1.495 | 4,228 |
| 2022-12-28 | 1.500 | 1.500 | 1.430 | 1.445 | 1.445 | 17,168 |
| 2022-12-27 | 1.640 | 1.640 | 1.415 | 1.580 | 1.580 | 13,594 |
| 2022-12-23 | 1.650 | 1.650 | 1.355 | 1.610 | 1.610 | 18,538 |
| 2022-12-22 | 1.615 | 1.630 | 1.500 | 1.630 | 1.630 | 8,702 |
| 2022-12-21 | 1.450 | 1.600 | 1.450 | 1.600 | 1.600 | 78,100 |
| 2022-12-20 | 1.380 | 1.450 | 1.305 | 1.400 | 1.400 | 18,991 |
Stock splits
No stock splits on record.
Dividends
No dividends on record.
Open, high, low and close are as traded (CHF). Adjusted close accounts for splits and dividends. Educational only, not financial advice.